4.6 Review

Lipotoxicity in the heart

Publisher

ELSEVIER
DOI: 10.1016/j.bbalip.2009.09.023

Keywords

Heart; Diabetes; Obesity; Lipotoxicity

Funding

  1. NIH [5T32 HL007576]
  2. American Heart Association
  3. National Institutes of Health [UO1 HL70525, UO1 HL087947, RO1 HL70070, RO1 HL73167]
  4. Juvenile Diabetes Research Foundation
  5. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL087947, T32HL007576, R01HL073167, U01HL070525, R01HL070070, R01HL108379] Funding Source: NIH RePORTER
  6. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092065] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Obesity and insulin resistance are associated with ectopic lipid deposition in multiple tissues, including the heart. Excess lipid may be stored as triglycerides, but are also shunted into non-oxidative pathways that disrupt normal cellular signaling leading to organ dysfunction and in some cases apoptosis, a process termed lipotoxicity. Various pathophysiological mechanisms have been proposed to lead to lipotoxic tissue injury, which might vary by cell type. Specific mechanisms by which lipotoxicity alter cardiac structure and function are incompletely understood, but are beginning to be elucidated. This review will focus on mechanisms that have been proposed to lead to lipotoxic injury in the heart and will review the state of knowledge regarding potential causes and correlates of increased myocardial lipid content in animal models and humans. We will seek to highlight those areas where additional research is warranted. (C) 2009 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available